NCT05159128View on ClinicalTrials.gov

A Study of JNJ-75105186 in Healthy Japanese and Chinese Participants

PHASE1WithdrawnINTERVENTIONAL
0
Timeline

Start Date

November 15, 2021

Primary Completion Date

April 2, 2022

Study Completion Date

April 2, 2022

Conditions
Healthy
Interventions
DRUG

JNJ-75105186

JNJ-75105186 will be administered orally in Part 1 and 2.

OTHER

Placebo

Matching placebo to JNJ-75105186 will be administered orally in Parts 1 and 2.

Trial Locations (1)

813-0017

Souseikai Fukuoka Mirai Hospital, Fukuoka

Sponsors
All Listed Sponsors
lead

Janssen Pharmaceutical K.K.

INDUSTRY